Specialist expertise
Target Identification & Therapeutic Candidate Screening
Target discovery support and High-Throughput Screening (HTS).
The science
About this capability
Target identification and therapeutic antibody candidate screening involve identifying disease-associated molecules (proteins, receptors) and selecting high-affinity antibodies through in-vivo/in-vitro screening. Key steps include validating targets using proteomics/genomics, utilizing hybridoma or phage display to generate candidates, and applying high-throughput screening for affinity, specificity, and developability.
Technical scope
- Target Discovery Support: Assist in selecting and validating bioconjugate or ADC targets with In-Vitro assessments.
- Hit-to-Lead with High-Throughput Screening (HTS) Approach: Optimize hits and leads with high-throughput screening and structure-activity relationship (SAR) studies.
Let’s work together
The right expertise.
For your next step.
Talk with our scientific team about your requirements,
technical feasibility, and timelines.
What happens next
- Share your requirementsTell us about your research goals, scope, and timelines.
- Scientific consultationOur scientists review feasibility and discuss the best approach with you.
- Proposal and quoteReceive a clear proposal covering scope, deliverables, timelines, and cost.